Thalidomide in patients with myelofibrosis with myeloid metaplasia.

被引：0
|
作者：
Barosi, G
Grossi, A
Comotti, B
Marchetti, M
机构：
[1] Policlin San Matteo, IRCCS, Lab Med Informat, I-27100 Pavia, Italy
[2] Policlin S Pietro, Hematol & Oncol Unit, Bergamo, Italy
[3] Policlin Careggi, Div Hematol, Florence, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3223
引用
收藏
页码：746A / 746A
页数：1
相关论文
共 50 条
  • [41] SERUM ERYTHROPOIETIN IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA
    BAROSI, G
    LIBERATO, LN
    GUARNONE, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (03) : 365 - 369
  • [42] Melphalan treatment in patients with myelofibrosis with myeloid metaplasia
    Petti, MC
    Latagliata, R
    Spadea, T
    Spadea, A
    Montefusco, E
    Spiriti, MAA
    Avvisati, G
    Breccia, M
    Pescarmona, E
    Mandelli, F
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (03) : 576 - 581
  • [43] Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia
    Barosi, G
    Vittorio, R
    Margherita, MS
    Luca, VG
    Alessandro, P
    Vittorio, N
    Isabella, R
    Rita, C
    Monia, M
    Mario, B
    Is, MNAEH
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (05) : 618 - 625
  • [44] The farnesyltransferase inhibitor, R115777, has significant in vitro activity in myelofibrosis with myeloid metaplasia.
    Mesa, RA
    Tefferi, A
    Gray, L
    Schroeder, G
    Kaufmann, SH
    BLOOD, 2001, 98 (11) : 469A - 470A
  • [45] Experimental investigations on the development of myeloid metaplasia.
    Sternberg, C
    BEITRAGE ZUR PATHOLOGISCHEN ANATOMIE UND ZUR ALLGEMEINEN PATHOLOGIE, 1909, 46 (03): : 586 - 601
  • [46] Plasma metalloproteinase (MMP) levels in patients with agnogenic myeloid metaplasia.
    Wang, JC
    Novetsky, A
    Chen, C
    BLOOD, 1998, 92 (10) : 257B - 257B
  • [47] Allogeneic blood cell transplantation following reduced intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
    Devine, SM
    Verma, A
    Shah, R
    Bradlow, BA
    Maynard, V
    Jessop, E
    Peace, D
    Huml, M
    Thomason, D
    Chen, YH
    Hoffman, R
    BLOOD, 2001, 98 (11) : 626A - 626A
  • [48] Clinical correlates of Technetium99m-sulfur colloid bone marrow scans in patients with myelofibrosis with myeloid metaplasia.
    Mesa, RA
    Wiseman, GA
    Li, CY
    Schroeder, G
    Gray, L
    Tefferi, A
    BLOOD, 2002, 100 (11) : 801A - 801A
  • [49] Ascorbic acid appears to increase the in vitro specificity and sensitivity of arsenic trioxide to the inhibition of primary myeloid colonies from patients with myelofibrosis with myeloid metaplasia.
    Mesa, RA
    Tefferi, A
    Powell, H
    Lasho, T
    Kaufmann, SH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 587S - 587S
  • [50] New experimental articles on the question of the myeloid metaplasia.
    Werzberg, A
    VIRCHOWS ARCHIV FUR PATHOLOGISCHE ANATOMIE UND PHYSIOLOGIE UND FUR KLINISCHE MEDIZIN, 1911, 204 (02): : 272 - 272
12345